Company news
Axsome Therapeutics, Inc. news in 2021
Axsome Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
November 7, 2021
Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021
October 19, 2021
Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million
October 17, 2021
Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
September 15, 2021
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine
September 13, 2021
Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder
August 22, 2021
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
August 8, 2021
Axsome Therapeutics Announces AXS-05 Achieves Primary and Key Secondary Endpoints in the MERIT Phase 2 Trial in Treatment Resistant Depression
August 8, 2021
Axsome Therapeutics to Report Second Quarter 2021 Financial Results on August 9, 2021
July 14, 2021
Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia
June 14, 2021
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
May 9, 2021
Axsome Therapeutics Joins Mental Health America and other Advocacy Organizations in Raising Awareness and Providing Support for Mental Health During Mental Health Month
May 6, 2021
Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021
April 26, 2021
Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder
April 25, 2021
Axsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
February 28, 2021
Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
February 15, 2021
Calls in 2021
- Axsome Therapeutics (NASDAQ:AXSM) Q3 2021 Earnings Call
Nov 8, 2021
Transcript - Axsome Therapeutics (NASDAQ:AXSM) Q2 2021 Earnings Call
Aug 9, 2021
Transcript - Axsome Therapeutics (NASDAQ:AXSM) Q1 2021 Earnings Call
May 10, 2021
Transcript - Axsome Therapeutics (NASDAQ:AXSM) Q4 2020 Earnings Call
Mar 1, 2021
Transcript
Decks in 2021
- American Headache Society Virtual Annual Scientific Meeting 2021
Conference · 11 slides · June 2021
- SVB Leerink Global Healthcare Conference 2021
Conference · 22 slides · Feb 24, 2021